In summary, findings presented here suggest that HSP90 N‐terminal inhibitors induce autophagic degradation of MORC2 in a HSP90‐independent manner through disrupting its homodimerization and are effective against MORC2‐expressing breast tumours irrespective of HSP90 expression status. Here, HSP90AB1 is linked to breast neoplasm.